{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,7]],"date-time":"2025-10-07T05:43:38Z","timestamp":1759815818269,"version":"build-2065373602"},"reference-count":40,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2018,3,1]],"date-time":"2018-03-01T00:00:00Z","timestamp":1519862400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,3,1]],"date-time":"2018-03-01T00:00:00Z","timestamp":1519862400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jaad.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of the American Academy of Dermatology"],"published-print":{"date-parts":[[2018,3]]},"DOI":"10.1016\/j.jaad.2017.10.042","type":"journal-article","created":{"date-parts":[[2017,11,3]],"date-time":"2017-11-03T20:16:43Z","timestamp":1509740203000},"page":"515-521.e4","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":13,"title":["Subclinical sensitization with diphenylcyclopropenone is sufficient for the treatment of alopecia areata: Retrospective analysis of 159 cases"],"prefix":"10.1016","volume":"78","author":[{"given":"Sung Jay","family":"Choe","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Solam","family":"Lee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Long Quan","family":"Pi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dong In","family":"Keum","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chung Hyeok","family":"Lee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Beom Jun","family":"Kim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Won-Soo","family":"Lee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jaad.2017.10.042_bib1","doi-asserted-by":"crossref","first-page":"722","DOI":"10.5021\/ad.2014.26.6.722","article-title":"Differences\u00a0in comorbidity profiles between early-onset and late-onset\u00a0alopecia areata patients: a retrospective study of 871 Korean patients","volume":"26","author":"Lee","year":"2014","journal-title":"Ann Dermatol"},{"key":"10.1016\/j.jaad.2017.10.042_bib2","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1111\/1346-8138.13613","article-title":"Efficacy and safety of superficial\u00a0cryotherapy for alopecia areata: a retrospective, comprehensive review of 353 cases over 22 years","volume":"44","author":"Jun","year":"2017","journal-title":"J Dermatol"},{"key":"10.1016\/j.jaad.2017.10.042_bib3","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/j.jaad.2009.10.031","article-title":"Alopecia areata update: part II. Treatment","volume":"62","author":"Alkhalifah","year":"2010","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.jaad.2017.10.042_bib4","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1007\/s40257-014-0086-4","article-title":"Alopecia areata: an evidence-based treatment update","volume":"15","author":"Hordinsky","year":"2014","journal-title":"Am J Clin Dermatol"},{"key":"10.1016\/j.jaad.2017.10.042_bib5","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1111\/j.1529-8019.2011.01422.x","article-title":"Dermatologic therapy: alopecia areata update","volume":"24","author":"Shapiro","year":"2011","journal-title":"Dermatol Ther"},{"key":"10.1016\/j.jaad.2017.10.042_bib6","doi-asserted-by":"crossref","first-page":"916","DOI":"10.1111\/j.1365-2133.2012.10955.x","article-title":"British Association of Dermatologists' guidelines for the management of alopecia areata 2012","volume":"166","author":"Messenger","year":"2012","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.jaad.2017.10.042_bib7","doi-asserted-by":"crossref","first-page":"1629","DOI":"10.1001\/archderm.1978.01640230003001","article-title":"Dinitrochlorobenzene therapy for alopecia areata","volume":"114","author":"Happle","year":"1978","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.jaad.2017.10.042_bib8","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1038\/jidsymp.2015.28","article-title":"Clinical efficacy of diphenylcyclopropenone in alopecia areata: retrospective data analysis of 50 patients","volume":"17","author":"Chiang","year":"2015","journal-title":"J Investig Dermatol Symp Proc"},{"key":"10.1016\/j.jaad.2017.10.042_bib9","doi-asserted-by":"crossref","first-page":"e400","DOI":"10.1111\/jdv.12009","article-title":"Efficacy and safety of diphenylcyclopropenone among Chinese patients with steroid resistant and extensive alopecia areata","volume":"27","author":"Luk","year":"2013","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"10.1016\/j.jaad.2017.10.042_bib10","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1111\/j.1468-3083.2011.04114.x","article-title":"Topical immunotherapy with diphenylcyclopropenone of patients with alopecia areata\u2014a large retrospective study on 142 patients with a self-controlled design","volume":"26","author":"Ohlmeier","year":"2012","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"10.1016\/j.jaad.2017.10.042_bib11","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1111\/j.1468-3083.2009.03401.x","article-title":"Five-year experience in the treatment of alopecia areata with DPC","volume":"24","author":"El-Zawahry","year":"2010","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"10.1016\/j.jaad.2017.10.042_bib12","first-page":"48","article-title":"Topical immunotherapy with diphenylcyclopropenone in the treatment of chronic extensive alopecia areata","volume":"32","author":"Sotiriadis","year":"2007","journal-title":"Clin Exp Dermatol"},{"key":"10.1016\/j.jaad.2017.10.042_bib13","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1186\/1471-5945-5-6","article-title":"Topical immunotherapy of severe alopecia areata with diphenylcyclopropenone (DPCP): experience in an Iranian population","volume":"5","author":"Aghaei","year":"2005","journal-title":"BMC Dermatol"},{"key":"10.1016\/j.jaad.2017.10.042_bib14","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1067\/mjd.2001.109309","article-title":"The\u00a0use of topical diphenylcyclopropenone for the treatment of extensive alopecia areata","volume":"44","author":"Cotellessa","year":"2001","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.jaad.2017.10.042_bib15","first-page":"1063","article-title":"Predictive model for immunotherapy of alopecia areata with diphencyprone","volume":"137","author":"Wiseman","year":"2001","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.jaad.2017.10.042_bib16","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1046\/j.1365-2133.1996.119854.x","article-title":"Topical diphencyprone for alopecia areata: evaluation of 48 cases after 30 months' follow-up","volume":"134","author":"Gordon","year":"1996","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.jaad.2017.10.042_bib17","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1016\/0190-9622(91)70037-3","article-title":"Treatment of alopecia areata with diphenylcyclopropenone","volume":"24","author":"van der Steen","year":"1991","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.jaad.2017.10.042_bib18","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.1365-2133.1987.tb04084.x","article-title":"Control of the immune response to contact sensitizing chemicals by cutaneous antigen-presenting cells","volume":"117","author":"Botham","year":"1987","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.jaad.2017.10.042_bib19","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1111\/j.1365-2133.1990.tb07298.x","article-title":"Alopecia areata treated with diphencyprone: is an allergic response necessary?","volume":"122","author":"Hull","year":"1990","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.jaad.2017.10.042_bib20","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1016\/j.jaad.2015.04.064","article-title":"Squaric acid sensitization is not required for response in the treatment of alopecia areata","volume":"73","author":"Vedak","year":"2015","journal-title":"J\u00a0Am Acad Dermatol"},{"key":"10.1016\/j.jaad.2017.10.042_bib21","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1016\/j.autrev.2016.02.021","article-title":"Modified immunotherapy for alopecia areata","volume":"15","author":"Yoshimasu","year":"2016","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.jaad.2017.10.042_bib22","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1016\/j.jaad.2003.09.032","article-title":"Alopecia areata investigational assessment guidelines\u2014part II. National Alopecia Areata Foundation","volume":"51","author":"Olsen","year":"2004","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.jaad.2017.10.042_bib23","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1016\/j.jaad.2017.03.015","article-title":"Systematic review and quality analysis of studies on the efficacy of topical diphenylcyclopropenone treatment for alopecia areata","volume":"77","author":"Jang","year":"2017","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.jaad.2017.10.042_bib24","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1016\/0190-9622(91)70032-W","article-title":"Prognostic factors in the treatment of alopecia areata with diphenylcyclopropenone","volume":"24","author":"van der Steen","year":"1991","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.jaad.2017.10.042_bib25","doi-asserted-by":"crossref","first-page":"96","DOI":"10.4103\/0974-7753.90816","article-title":"Practicality in using diphenyl cyclo propenone for alopecia areata","volume":"3","author":"Muthuvel","year":"2011","journal-title":"Int J Trichology"},{"key":"10.1016\/j.jaad.2017.10.042_bib26","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1016\/S0733-8635(18)30255-9","article-title":"Topical immunotherapy of alopecia areata","volume":"11","author":"van der Steen","year":"1993","journal-title":"Dermatol Clin"},{"key":"10.1016\/j.jaad.2017.10.042_bib27","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1080\/09546630410023601","article-title":"Topical immunomodulator therapy with squaric acid dibutylester (SADBE) is effective treatment for severe alopecia areata (AA): results of an open-label, paired-comparison, clinical trial","volume":"16","author":"Dall'oglio","year":"2005","journal-title":"J Dermatolog Treat"},{"key":"10.1016\/j.jaad.2017.10.042_bib28","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1046\/j.1365-2133.2001.04399.x","article-title":"The therapeutic use of topical contact sensitizers in benign dermatoses","volume":"145","author":"Buckley","year":"2001","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.jaad.2017.10.042_bib29","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1016\/S0190-9622(84)80091-2","article-title":"Topical therapy of alopecia areata with squaric acid dibutylester","volume":"10","author":"Case","year":"1984","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.jaad.2017.10.042_bib30","doi-asserted-by":"crossref","first-page":"1277","DOI":"10.1016\/j.jaci.2015.06.032","article-title":"Alopecia areata profiling shows TH1, TH2, and IL-23 cytokine activation without parallel TH17\/TH22 skewing","volume":"136","author":"Suarez-Farinas","year":"2015","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaad.2017.10.042_bib31","first-page":"873","article-title":"Lee Seung-Hun. Comparison in expression of CD1, HLA-DR, and ICAM-1 of follicular keratinocytes from a lesion and a non-lesional scalp of alopecia areata","volume":"66","author":"Lee Won-Soo","year":"1995","journal-title":"Korean J Dermatol"},{"key":"10.1016\/j.jaad.2017.10.042_bib32","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1111\/1523-1747.ep12470601","article-title":"Immunohistologic and ultrastructural comparison of the dermal papilla and hair follicle bulb from \u201cactive\u201d and \u201cnormal\u201d areas of alopecia areata","volume":"96","author":"Hull","year":"1991","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.jaad.2017.10.042_bib33","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1097\/DAD.0b013e318185a66e","article-title":"Investigation of the inflammatory mechanisms in alopecia areata","volume":"31","author":"Cetin","year":"2009","journal-title":"Am J Dermatopathol"},{"key":"10.1016\/j.jaad.2017.10.042_bib34","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1111\/1523-1747.ep12277414","article-title":"Expression of HLA-DR by anagen hair follicles in alopecia areata","volume":"85","author":"Messenger","year":"1985","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.jaad.2017.10.042_bib35","first-page":"537","article-title":"Diphenylcyclopropenone treatment of\u00a0alopecia areata induces apoptosis of perifollicular lymphocytes","volume":"16","author":"Herbst","year":"2006","journal-title":"Eur J Dermatol"},{"key":"10.1016\/j.jaad.2017.10.042_bib36","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1007\/s00403-007-0759-4","article-title":"Changes in distribution pattern of CD8 lymphocytes in the scalp in alopecia areata during treatment with diphencyprone","volume":"299","author":"Wasylyszyn","year":"2007","journal-title":"Arch Dermatol Res"},{"key":"10.1016\/j.jaad.2017.10.042_bib37","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1111\/1346-8138.12740","article-title":"Effective squaric acid dibutylester immunotherapy is associated with a reduction of skin infiltrating T-helper (Th)1 and Th17 cells in alopecia areata patients","volume":"42","author":"Avitabile","year":"2015","journal-title":"J Dermatol"},{"key":"10.1016\/j.jaad.2017.10.042_bibE1","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1016\/j.jaad.2003.09.032","article-title":"Alopecia areata investigational assessment guidelines\u2014part II. National Alopecia Areata Foundation","volume":"51","author":"Olsen","year":"2004","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.jaad.2017.10.042_bibE2","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1016\/j.jdermsci.2010.03.009","article-title":"Experimental evaluation of ebastine, a second-generation anti-histamine, as a supportive medication for alopecia areata","volume":"58","author":"Ohyama","year":"2010","journal-title":"J Dermatol Sci"},{"key":"10.1016\/j.jaad.2017.10.042_bibE3","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1111\/j.1346-8138.2009.00647.x","article-title":"Fexofenadine hydrochloride enhances the efficacy of contact immunotherapy for extensive alopecia areata: retrospective analysis of 121 cases","volume":"36","author":"Inui","year":"2009","journal-title":"J Dermatol"}],"container-title":["Journal of the American Academy of Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0190962217326002?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0190962217326002?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,30]],"date-time":"2025-09-30T22:45:16Z","timestamp":1759272316000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0190962217326002"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,3]]},"references-count":40,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2018,3]]}},"alternative-id":["S0190962217326002"],"URL":"https:\/\/doi.org\/10.1016\/j.jaad.2017.10.042","relation":{},"ISSN":["0190-9622"],"issn-type":[{"type":"print","value":"0190-9622"}],"subject":[],"published":{"date-parts":[[2018,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Subclinical sensitization with diphenylcyclopropenone is sufficient for the treatment of alopecia areata: Retrospective analysis of 159 cases","name":"articletitle","label":"Article Title"},{"value":"Journal of the American Academy of Dermatology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jaad.2017.10.042","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 by the American Academy of Dermatology, Inc.","name":"copyright","label":"Copyright"}]}}